Chapel Hill, North Carolina (NC) Biological Products, Except Diagnostic Substances Companies

Featured companies
Aron Christpher Chnnes Fndtion
324 Dalton Dr.
Chapel Hill NC 27517
(919) 932-3842
John T Kartesz Dr
9319 Bracken Ln.
Chapel Hill NC 27516
(919) 967-6240
Innatrix Inc
250 Bell Tower Drive
Chapel Hill NC 27599
(919) 962-4736
Not satisfied? Select a reasonRate this pageSend feedback

Or try our search form or quick navigation by category and location

Amniocell Therapeutics
870 Martin Luther King Jr
Chapel Hill NC 27514
(919) 933-4990
Biota of North America Program
9319 Bracken Lane
Chapel Hill NC 27516
(919) 967-6240
Chatham Therapeutics LLC
45 North Chatham Parkway
Chapel Hill NC 27517
(919) 968-2727
Forsight Pharmaceuticals Inc
870 Martin Luther K
Chapel Hill NC 27514
(919) 933-4990
Genecine Corp
203 Christine Court
Chapel Hill NC 27516
(919) 929-7886
Ligamar Inc
1829 East Franklin St Building 6
Chapel Hill NC 27514
(919) 967-6029
Molecular Orthopaedics Inc
870 Mrtin Lther King Boulevard
Chapel Hill NC 27514
(919) 933-4990
Whereorg has 14 results under Biological Products, Except Diagnostic Substances Companies in Chapel Hill, NC.

Narrow down the browsing criteria below to see more companies.

Select a category for location Orange, North Carolina

Other locations for category Biological Products, Except Diagnostic Substances


Top Stories
UBS flags buyback possibility after Second-quarter earnings beat
UBS , the world's largest wealth manager, on Tuesday signalled the possibility of resuming share buybacks later this year after generating more income than expected in the first six months and as it boosted...
Tue, Jul 21 2020
Greece calls EU recovery fund deal a 'national success'
Prime Minister Kyriakos Mitsotakis called a European Union deal on a post-pandemic recovery fund a "national success" that would allocate Greece around 72 billion euros ($82.38 billion) to help deal with...
Tue, Jul 21 2020
UBS second-quarter net profit dips as Swiss business dampens trading bonanza
UBS , the world's largest wealth manager, saw net profit drop 11% in the second quarter as higher trading activity failed to offset a pandemic-induced slump in retail and corporate banking.
Tue, Jul 21 2020